Repurposed amyotrophic lateral sclerosis drug becomes imaging probe to help diagnose neurodegeneration
Positron emission tomography (PET) is a nuclear imaging technique used to diagnose conditions such as cancer. An innovative ...
DiagnaMed Granted FDA Orphan Drug Designation for Molecular Hydrogen to Treat Amyotrophic Lateral Sclerosis
DiagnaMed Holdings Corp. (CSE: DMED) (OTCQB: DGNMF) ("DiagnaMed", "DMED", or the "Company"), a leading provider of ...
Medical Xpress6d
Four immunoassays for neurofilament light chain show consistent performance in amyotrophic lateral sclerosis
Four immunoassays for neurofilament light chain (NfL) demonstrate consistent performance in patients with amyotrophic lateral ...
idw1h
Diagnosing Alzheimer’s disease using blood tests: p-tau biomarkers not as disease-specific as previously thought
< Professor Markus Otto at the microscope: In a study, he and his colleagues showed that p-tau protein ... University Medicine Halle ...
PathMaker Neurosystems Announces Issuance of Three Patents Protecting the Use of Company’s Proprietary Neuromodulation Technology in ALS
"We are gratified to see these latest patent issuances," said Nader Yaghoubi, M.D., Ph.D., PathMaker’s Co-Founder and CEO. "We have been pioneering the application of neuromodulation to ALS, and these ...
This Motor Neurone Disease symptom in the mouth can be overlooked - see a doctor if you have it
MND Scotland says that around 450 people in the country are living with Motor Neurone Disease. One symptom that can easily be ...
Blood test can help diagnose, track ALS patients, French study indicates
A blood test can help doctors detect ALS, or amyotrophic lateral sclerosis, and predict how the degenerative disease will ...
StudyFinds on MSN2d
Breakthrough blood test could transform ALS diagnosis, care
Find out about the new ALS blood test that offers accurate diagnosis and could replace traditional invasive testing methods.
Neurology Advisor5h
Four Immunoassays for Neurofilament Light Chain Show Consistent Performance in ALS
There are 4 immunoassays for neurofilament light chain that demonstrate consistent performance in patients with ALS.
Athira Pharma Reports Full Year 2024 Financial Results and Pipeline and Business Updates
Completed healthy volunteer Phase 1 clinical study of ATH-1105 as a potential treatment for amyotrophic lateral sclerosis (ALS)On-track to enable ...
DiagnaMed Holdings Corp.: DiagnaMed Granted FDA Orphan Drug Designation for Molecular Hydrogen to Treat Amyotrophic Lateral Sclerosis
DiagnaMed Holdings Corp. (CSE: DMED) (OTCQB: DGNMF) ("DiagnaMed", "DMED", or the "Company"), a leading provider of cutting-edge technology solutions ...